Plasmapheresis in the dysproteinemias

Therapeutic Apheresis

Volumn 6, Issue 1, 2002, Pages 45-52

  Drew, Mary Jo ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Amyloidosis; Cryofibrinogenemia; Cryofiltration apheresis; Cryoglobulinemia; Dysproteinemia; Hyperviscosity; Immunoadsorption; Light chain disease; Membrane separation; Monoclonal gammopathy; Multiple myeloma; Plasmapheresis; Waldenstr m's macroglobulinemia

Indexed keywords

AMYLOIDOSIS; ARTICLE; AUTOMATION; CLINICAL FEATURE; CRYOFIBRINOGENEMIA; CRYOGLOBULINEMIA; DYSPROTEINEMIA; EUROPE; HUMAN; HYPERVISCOSITY SYNDROME; IMMUNOADSORPTION; IMMUNOGLOBULIN LIGHT CHAIN DISEASE; JAPAN; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PERTHES DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL;

AMYLOIDOSIS; BLOOD PROTEIN DISORDERS; CENTRIFUGATION; CRYOGLOBULINEMIA; HUMANS; MULTIPLE MYELOMA; PARAPROTEINEMIAS; PLASMAPHERESIS; WALDENSTROM MACROGLOBULINEMIA;

EID: 0036124551     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00393.x     Document Type: Article

References (48)

1. Therapeutic plasma exchange in hematologic diseases and dysproteinemias
2. Plasmapheresis and paraproteinemia: Cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis
3. Introduction to the third special issue: Clinical applications of therapeutic apheresis
4. Cryoglobulins and cryoglobulinemia
5. Biological and clinical significance of cryoglobulins: A report of 86 cases
6. Association between hepatitis C virus and mixed cryoglobulinemia
7. Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital
8. Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspective
9. Hepatitis C infection and cryoglobulinemia
10. Cryofiltration apheresis for treatment of cryoglobulinemia associated with hepatitis C
11. Cryofiltration apheresis in the United States
12. Cryofibrinogenemia: An addition to the differential diagnosis of calciphylaxis in end-stage renal disease
13. Waldenström's macroglobulinemia
14. Peripheral neuropathy in macroglobulinemia: Incidence and antigen-specificity of M proteins
15. Nephrotic syndrome caused by protein thrombi in glomerulocapillary lumen in Waldenström's macroglobulinemia
16. Plasma exchange in dysproteinemias
17. Hyperviscosity syndromes associated with immunoglobulin abnormalities
18. Central retinal vein occlusion due to hyperviscosity syndrome
19. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance
20. Neuropathies associated with monoclonal gammopathies
21. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
22. Biology, clinical patterns and treatment of multiple myeloma and related plasma cell dyscrasias
23. The treatment of multiple myeloma
24. Renal failure in multiple myeloma: Reversibility and impact on prognosis
25. A unique case of kappa light chain disease associated with cryoglobulinemia, pyroglobulinemia, and hyperviscosity syndrome
26. Light chain nephropathy
27. Are selective macromolecule removal plasmapheresis systems useful for auto-immune diseases or hyperlipidemia?
28. Clinical trials of cryoglobulin filter
29. Cryofiltration apheresis in the treatment of cryoprecipitate-induced diseases
30. Effect of plasmapheresis (PP) corticosteroids, and cyclophosphamide in essential polyclonal globulinemia associated with glomerulonephritis
31. Plasmapheresis as sole therapy in a patient with essential mixed cryoglobulinemia
32. Efficacy of discontinuous flow centrifugation compared with cascade filtration in Waldenström's macroglobulinemia
33. The hyperviscosity syndrome
34. Plasmapheresis in hyperviscosity syndrome
35. Plasma exchange in the long-term management of Waldenström's macroglobulinemia
36. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gamniopathy
37. Neuropathies associated with paraproteinemia
38. Successful management of paraprotein-associated peripheral neuropathies by immunoadsorption of plasma with staphylococcal protein A
39. An unexpected complication following immunoadsorption with staphylococcal protein A column
40. Controlled plasma exchange trial in acute renal failure due to multiple myeloma
41. Management of myeloma kidney: An anti-light chain approach
42. Clearance of Bence-Jones proteins during peritoneal dialysis or plasmapheresis in myelomatosis associated with renal failure
43. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy
44. Serum-free light chain analysis by crossed immunoelectrophoresis: Correlation with plasmapheresis in light chain disease nephropathy
45. Myeloma kidney
46. Rapidly progressive glomerulonephritis associated with amyloidosis: Efficacy of plasma exchange
47. A new treatment for dialysis-related amyloidosis with beta 2-microglobulin column